tradingkey.logo

Merck Issues Statement On Potential Reduced Dosing Recommendation For Gardasil 9

ReutersMay 23, 2025 6:06 PM

- Merck & Co Inc MRK.N:

  • MERCK STATEMENT ON A POTENTIAL REDUCED DOSING RECOMMENDATION FOR GARDASIL®9

  • AFFIRMED POSITION REGARDING ALTERNATE DOSING REGIMENS FOR GARDASIL®9 FOR PREVENTION OF CERTAIN HPV-RELATED CANCERS AND DISEASES - WEBSITE

  • UNTIL THERE ARE SUFFICIENT DATA FOR FDA & EC TO LICENSE OTHER GARDASIL 9 REGIMEN, CDC VIEW SHOULD REMAIN CONSISTENT WITH APPROVED LABELING

  • SOUGHT GUIDANCE FROM FDA REGARDING ITS PROPOSED SINGLE DOSE TRIAL DESIGNS FOR GARDASIL 9

  • FDA WAS CLEAR ABOUT "HIGH STANDARD OF EVIDENCE" THAT WOULD BE REQUIRED FOR LICENSURE OF SINGLE DOSE REGIMENS FOR GARDASIL 9

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI